- Datametrex AI (DM) has received requests from its film and television production clients to increase weekly COVID testing due to the Omicron SARS-CoV-2 variant
- The additional COVID testing will lead to a significant increase in revenue
- In the third quarter of 2021, Datametrex administered over 67,500 tests to 41 production companies
- Datametrex AI is a technology focused company with exposure to AI and machine learning
- Datametrex AI Ltd. (DM) opened trading at $0.19 per share
Datametrex AI (DM) has received requests from its film and television production clients to increase weekly COVID testing.
Clients have requested that Datametrex conduct tests every 24-hours, instead of the previous 72-hour rotation.
In the third quarter of 2021, Datametrex administered over 67,500 tests for 41 production companies in Montreal, Toronto and Vancouver.
“The company is pleased to be able to accommodate the need from the film and production companies. With 24-hour Covid-19 testing rotations, we anticipate a significant increase in revenue in the COVID-19 business,” said Marshall Gunter, CEO of the Company.
“With the new Omicron variants spreading, management feels that continued testing will be necessary for the foreseeable future as part of the answer to keep people safe and sound,” said Andrew Ryu, Chairman of the Company.
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.
Datametrex AI Ltd. (DM) opened trading at $0.19 per share.
